Sio Gene Therapies Inc. Basic Shares Outstanding (Weighted Average)
Sio Gene Therapies Inc. reported Basic Shares Outstanding (Weighted Average) of 73.98 million shares for the 3-month period ending 2022-12-31, per its 10-Q filed 2023-02-14.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2023-02-14
- Sio Gene Therapies Inc. weighted average number of shares outstanding, basic for the quarter ending 2022-12-31 was 73.98M shares, a 0.87% increase year-over-year.
- Sio Gene Therapies Inc. weighted average number of shares outstanding, basic for the quarter ending 2022-09-30 was 73.98M shares, a 1.42% increase year-over-year.
- Sio Gene Therapies Inc. weighted average number of shares outstanding, basic for the quarter ending 2022-06-30 was 73.77M shares, a 1.24% increase year-over-year.
- Sio Gene Therapies Inc. weighted average number of shares outstanding, basic for the quarter ending 2022-03-31 was 73.71M shares, a 11.71% increase year-over-year.
- Sio Gene Therapies Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 73.21M shares, a 40.30% increase from fiscal 2021.
- Sio Gene Therapies Inc. weighted average number of shares outstanding, basic for fiscal 2021 was 52.18M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2022-12-31 | 73.98M shares 10-Q · filed 2023-02-14 | 73.98M shares derived: average of 2 quarters · filed 2023-02-14 | 73.91M shares 10-Q · filed 2023-02-14 | 73.86M shares derived: average of 4 quarters · filed 2023-02-14 |
| 2022-09-30 | 73.98M shares 10-Q · filed 2022-11-10 | 73.87M shares 10-Q · filed 2022-11-10 | 73.82M shares derived: average of 3 quarters · filed 2022-11-10 | 73.70M shares derived: average of 4 quarters · filed 2023-02-14 |
| 2022-06-30 | 73.77M shares 10-Q · filed 2022-08-11 | 73.74M shares derived: average of 2 quarters · filed 2022-08-11 | 73.60M shares derived: average of 3 quarters · filed 2023-02-14 | 73.44M shares derived: average of 4 quarters · filed 2023-02-14 |
| 2022-03-31 | 73.71M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-14 | 73.52M shares derived: average of 2 quarters · filed 2023-02-14 | 73.33M shares derived: average of 3 quarters · filed 2023-02-14 | 73.21M shares 10-K · filed 2022-06-14 |
| 2021-12-31 | 73.34M shares 10-Q · filed 2023-02-14 | 73.14M shares derived: average of 2 quarters · filed 2023-02-14 | 73.05M shares 10-Q · filed 2023-02-14 | 71.28M shares derived: average of 4 quarters · filed 2023-02-14 |
| 2021-09-30 | 72.94M shares 10-Q · filed 2022-11-10 | 72.90M shares 10-Q · filed 2022-11-10 | 70.59M shares derived: average of 3 quarters · filed 2022-11-10 | 66.12M shares derived: average of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | 72.86M shares 10-Q · filed 2022-08-11 | 69.42M shares derived: average of 2 quarters · filed 2022-08-11 | 63.84M shares derived: average of 3 quarters · filed 2022-08-11 | 59.56M shares derived: average of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | 65.98M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-14 | 59.33M shares derived: average of 2 quarters · filed 2022-06-14 | 55.13M shares derived: average of 3 quarters · filed 2022-06-14 | 52.18M shares 10-K · filed 2022-06-14 |
| 2020-12-31 | 52.68M shares 10-Q · filed 2022-02-11 | 49.71M shares derived: average of 2 quarters · filed 2022-02-11 | 47.58M shares 10-Q · filed 2022-02-11 | |
| 2020-09-30 | 46.73M shares 10-Q · filed 2021-11-12 | 45.02M shares 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | 43.29M shares 10-Q · filed 2021-08-12 |